Vonovia SE : Close to a major long term resistance level
Entry price | Target | Stop-loss | Potential |
---|
€40.99 |
€38.7 |
€41.95 |
+5.59% |
---|
The breach of the resistance zone around 41.95 EUR seems hard to achieve. The most probable scenario therefore seems to be one in which a short term correction takes place for shares in Vonovia.
Strengths● The group's activity appears highly profitable thanks to its outperforming net margins.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● This company will be of major interest to investors in search of a high dividend stock.
● Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
● For the past twelve months, EPS forecast has been revised upwards.
● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
● Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 41.95.
● The stock is close to a major daily resistance at EUR 42.41, which should be gotten rid of so as to gain new appreciation potential.
● One of the major weak points of the company is its financial situation.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
● The company's "enterprise value to sales" ratio is among the highest in the world.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.